Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Other Non-Current Liabilities (2021 - 2025)

Rxo's Other Non-Current Liabilities history spans 5 years, with the latest figure at $69.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 16.87% year-over-year to $69.0 million; the TTM value through Dec 2025 reached $69.0 million, down 16.87%, while the annual FY2025 figure was $69.0 million, 16.87% down from the prior year.
  • Other Non-Current Liabilities reached $69.0 million in Q4 2025 per RXO's latest filing, down from $71.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $88.0 million in Q1 2025 to a low of $36.0 million in Q3 2022.
  • Average Other Non-Current Liabilities over 5 years is $52.9 million, with a median of $41.0 million recorded in 2024.
  • The largest YoY upside for Other Non-Current Liabilities was 114.63% in 2025 against a maximum downside of 16.87% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $37.0 million in 2021, then increased by 8.11% to $40.0 million in 2022, then changed by 0.0% to $40.0 million in 2023, then skyrocketed by 107.5% to $83.0 million in 2024, then dropped by 16.87% to $69.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Other Non-Current Liabilities are $69.0 million (Q4 2025), $71.0 million (Q3 2025), and $70.0 million (Q2 2025).